Internal Medicine, Endocrinology, Diabetes, & Metabolism · Pembroke Pines, FL
NPI
1124006606
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
17901 NW 5th St, Suite 103
Pembroke Pines, FL, 33029
Phone (954) 964-2450
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
515 services
Medicare patients, 2024
72
Average age 73
Drug cost, 2024
$639K
1,620 prescriptions
Company payments, 2025
$182
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George Vargas was code 99214 (office e&m - established), 271 times for 70 patients. In total George Vargas billed 515 services in 11 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 271 | 70 | $89.51 | $24K |
| 76536 Ultrasound - Nonspecific | Office | 91 | 62 | $80.67 | $7,341 |
| 95923 Electrical Nerve Conductivity | Office | 77 | 51 | $91.89 | $7,076 |
| 99204 Office E&M - New | Office | 11 | 11 | $124.76 | $1,372 |
By year: 2022 $45K for 524 services; 2023 $38K for 444 services; 2024 $44K for 515 services.
Medicare prescription drug claims, 2024
In 2024, the drug George Vargas prescribed most often to Medicare patients was Lantus Solostar (Insulin Glargine,hum.Rec.Anlog), with 194 prescriptions and refills. In total George Vargas wrote 1,620 Medicare prescriptions that cost $639K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 194 | 426 | 73 | $52K |
| Levothyroxine Sodium Generic | 193 | 541 | 82 | $2,422 |
| Novolog Flexpen Insulin Aspart | 144 | 294 | 65 | $67K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 143 | 340 | 57 | $20K |
| Synthroid Levothyroxine Sodium | 128 | 338 | 39 | $17K |
| Metformin Hcl Generic | 88 | 253 | 41 | $857 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 64 | 120 | 21 | $29K |
| Ozempic Semaglutide | 59 | 70 | Under 11 | $64K |
| Januvia Sitagliptin Phosphate | 41 | 108 | 18 | $52K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 36 | 67 | 16 | $3,747 |
| Glipizide Generic | 32 | 92 | 17 | $1,063 |
| Rybelsus Semaglutide | 31 | 69 | 11 | $64K |
| Jardiance Empagliflozin | 25 | 63 | Under 11 | $32K |
| Droplet Pen Needle Pen Needle, Diabetic | 22 | 65 | Under 11 | $2,562 |
| Mounjaro Tirzepatide | 18 | 18 | Under 11 | $19K |
Brand drugs: 1,042 claims; generic drugs: 296 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George Vargas $182 ($182 in general payments such as food, travel and fees) from 6 companies. The largest payer was Mannkind Corporation with $65.16.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.